Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 3, Issue 5, pp. 512-519
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 20, 2012
- Revision received January 25, 2013
- Accepted January 28, 2013
- Published first March 28, 2013.
Article Versions
- Previous version (March 28, 2013 - 06:45).
- You are viewing the most recent version of this article.
Copyright & Usage
©2013 American Association for Cancer Research.
Author Information
- Lynn Bjerke1,2,
- Alan Mackay1,2,
- Meera Nandhabalan1,2,
- Anna Burford1,2,
- Alexa Jury1,2,
- Sergey Popov1,2,
- Dorine A. Bax1,2,
- Diana Carvalho1,2,6,7,
- Kathryn R. Taylor1,2,
- Maria Vinci1,2,
- Ilirjana Bajrami1,3,
- Imelda M. McGonnell4,
- Christopher J. Lord1,3,
- Rui M. Reis7,8,
- Darren Hargrave5,
- Alan Ashworth1,3,
- Paul Workman2 and
- Chris Jones1,2
- Authors' Affiliations: 1Divisions of Molecular Pathology and 2Cancer Therapeutics, and 3Breakthrough Breast Cancer Research Centre and CRUK Gene Function Laboratory, Division of Breast Cancer Research, The Institute of Cancer Research; 4Royal Veterinary College; 5Great Ormond Street Hospital, London, United Kingdom; 6University of Coimbra, Coimbra; 7ICVS, University of Minho, Braga, Portugal; and 8Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos SP, Brazil
- Corresponding Author:
Chris Jones, Glioma Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, United Kingdom. Phone: 44-020-8722-4416; Fax: 44-020-8722-4321; E-mail: chris.jones{at}icr.ac.uk
May 2013
Volume 3, Issue 5
Volume 3, Issue 5
Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
Jump to section
Advertisement